Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions
NCT00778557
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL
Sponsor
Ranbaxy Laboratories Limited